Loading stock data…
AngioDynamics (ANGO)
$13.59+0.15 (+1.12%)
Market ClosedLast close Jul 24
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
AngioDynamics, Inc. in the Healthcare sector is trading at $13.59 with a market capitalization of $501M. Wall Street consensus targets $20.00 (4 analysts), implying a +47.2% move over the next 12 months. The stock is currently 11% below its 52-week high of $15.20, remaining 16.3% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +47.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $86.61M↑ | $78.42M↓ | $79.43M↑ | $75.71M↓ | $80.16M |
| Gross Profit | $46.77M↑ | $41.48M↓ | $44.78M↑ | $41.86M↓ | $42.22M |
| Operating Income | -$5.51M↑ | -$6.43M↓ | -$2.49M↑ | -$7.90M↓ | -$3.63M |
| Net Income | -$11.40M↓ | -$8.08M↓ | -$6.35M↑ | -$10.90M↓ | -$6.05M |
Peer Comparison
JNJUNHPFE
Fundamentals
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internation...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$500.79M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-18.11%
Volume
Today's trading volume
314,788
Recent News
AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript
Med Tech revenue surged 16.7% as company shifts toward higher-margin products.
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands
ANGO's Q4 FY26 revenues rise 8% as Med Tech surges, while its adjusted loss beats estimates and FY27 sales guidance tops consensus.
AngioDynamics Inc (ANGO) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges
AngioDynamics Inc (ANGO) reports robust revenue increases driven by MedTech and NanoKnife segments, despite facing net losses and competitive market pressures.
AngioDynamics Q4 Earnings Call Highlights
AngioDynamics (NASDAQ:ANGO) reported higher fiscal fourth-quarter and full-year revenue, driven by continued growth in its med tech portfolio, while management said the company remains focused on balancing investment in clinical programs with profitability and cash generation. On the company’s fisc
AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates
AngioDynamics (ANGO) delivered earnings and revenue surprises of +36.36% and +7.61%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?